These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20425536)

  • 1. Intensity of warfarin coagulation in the antiphospholipid syndrome.
    Crowther M; Crowther MA
    Curr Rheumatol Rep; 2010 Feb; 12(1):64-9. PubMed ID: 20425536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome).
    Cuadrado MJ
    Curr Rheumatol Rep; 2002 Oct; 4(5):392-8. PubMed ID: 12217243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial.
    Pengo V; Banzato A; Bison E; Zoppellaro G; Padayattil Jose S; Denas G
    Lupus; 2016 Mar; 25(3):301-6. PubMed ID: 26466613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
    Finazzi G; Marchioli R; Brancaccio V; Schinco P; Wisloff F; Musial J; Baudo F; Berrettini M; Testa S; D'Angelo A; Tognoni G; Barbui T
    J Thromb Haemost; 2005 May; 3(5):848-53. PubMed ID: 15869575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of thrombosis in the antiphospholipid-antibody syndrome.
    Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
    N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.
    Arachchillage DR; Mackie IJ; Efthymiou M; Chitolie A; Hunt BJ; Isenberg DA; Khamashta M; Machin SJ; Cohen H
    J Thromb Haemost; 2016 Nov; 14(11):2177-2186. PubMed ID: 27541499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis.
    Crowther MA; Wisloff F
    Thromb Res; 2005; 115(1-2):3-8. PubMed ID: 15567446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].
    Kondrat'eva LV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Kovalenko TF; Ostriakova EV; Reshetniak TM
    Ter Arkh; 2010; 82(5):33-9. PubMed ID: 20597268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of thrombosis in antiphospholipid antibody syndrome.
    Petri M
    Rheum Dis Clin North Am; 2001 Aug; 27(3):633-42, viii. PubMed ID: 11534265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
    Cohen H; Hunt BJ; Efthymiou M; Arachchillage DR; Mackie IJ; Clawson S; Sylvestre Y; Machin SJ; Bertolaccini ML; Ruiz-Castellano M; Muirhead N; Doré CJ; Khamashta M; Isenberg DA;
    Lancet Haematol; 2016 Sep; 3(9):e426-36. PubMed ID: 27570089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis.
    Meroni PL; Moia M; Derksen RH; Tincani A; McIntyre JA; Arnout JM; Koike T; Piette JC; Khamashta MA; Shoenfeld Y
    Lupus; 2003; 12(7):504-7. PubMed ID: 12892388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulation for the antiphospholipid antibody syndrome: can we now say less is more?
    Anderson DR
    J Thromb Haemost; 2005 May; 3(5):846-7. PubMed ID: 15869574
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
    Crowther MA; Ginsberg JS; Julian J; Denburg J; Hirsh J; Douketis J; Laskin C; Fortin P; Anderson D; Kearon C; Clarke A; Geerts W; Forgie M; Green D; Costantini L; Yacura W; Wilson S; Gent M; Kovacs MJ
    N Engl J Med; 2003 Sep; 349(12):1133-8. PubMed ID: 13679527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of antiphospholipid antibody syndrome: a systematic review.
    Lim W; Crowther MA; Eikelboom JW
    JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aspirin and antiphospholipid syndrome].
    Hachulla E; Piette AM; Hatron PY; Blétry O
    Rev Med Interne; 2000 Mar; 21 Suppl 1():83s-88s. PubMed ID: 10763209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How much warfarin is enough in APS related thrombosis?
    Erkan D; Lockshin MD
    Thromb Res; 2004; 114(5-6):435-42. PubMed ID: 15507275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombosis in spite of warfarin--what should be done?].
    Lassila R
    Duodecim; 2001; 117(24):2632-6. PubMed ID: 12183826
    [No Abstract]   [Full Text] [Related]  

  • 18. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies.
    Ruiz-Irastorza G; Hunt BJ; Khamashta MA
    Arthritis Rheum; 2007 Dec; 57(8):1487-95. PubMed ID: 18050167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibody syndrome: recent findings on managing this challenging condition.
    Crowther MA
    Cleve Clin J Med; 2005 Mar; 72(3):245-9. PubMed ID: 15825803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation therapy in the antiphospholipid syndrome: recent advances.
    Ng HJ; Crowther MA
    Curr Opin Pulm Med; 2005 Sep; 11(5):368-72. PubMed ID: 16093807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.